Marit van Gils
Marit van Gils (1982) studied medical pharmaceutical sciences at the University of Groningen, the Netherlands. She has performed her Ph.D. research (2007-2011) at the University of Amsterdam in the lab of Dr. Schuitemaker on the humoral immune response after HIV-1 infection. She continued her career as a postdoctoral fellow in the lab of Dr. Sanders working on the development of an HIV protein vaccine at the Academic Medical Center in Amsterdam, the Netherlands. Marit has also performed part of her postdoctoral research at the Scripps Research Institute in the lab of Dr. Burton (2013-2016) and in 2017 started her own research group at the Amsterdam UMC, the Netherlands, studying the antibody and B cell responses after infection and vaccination, including HIV-1, Influenza and SARS-CoV-2.
Abstracts this author is presenting:
